Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS)

98.05 -0.43 (-0.44%) At close: 03:00PM CST

Shanghai MicroPort Endovascular MedTech Co., Ltd.

No. 1, Lane 3399
Pudong New Area Kangxin Road
Shanghai 201318
China
86 21 3813 9300
https://www.endovastec.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 908

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Qing Zhu	GM & Director	N/A	N/A	1981
Ms. Chun Fang Li	Accounting Supervisor & CFO	N/A	N/A	1980
Mr. Genyong Qiu	Deputy GM & Secretary of the Board of Directors	N/A	N/A	1977
Mr. Zhenyu Yuan	Deputy GM & Core Technical Personnel	N/A	N/A	1977
Mr. Lantao Guo	Deputy GM & Core Technical Personnel	N/A	N/A	1966
Mr. Ke Chen	Senior Director	N/A	N/A	1980
Ms. Hongjie Lu	Core Technical Staff	N/A	N/A	1983
Ms. Liwen Wang	Core Technical Staff	N/A	N/A	1982

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, and sale of aortic and peripheral vascular medical devices in China and internationally. Its products include thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems, aortic dissection, percutaneous transluminal angioplasty, and balloon catheters, as well as accessories, such as balloon inflation catheter. Shanghai MicroPort Endovascular MedTech Co., Ltd. was founded in 2012 and is based in Shanghai, the People's Republic of China.

Corporate governance

Shanghai MicroPort Endovascular MedTech Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.